Primary Site >> Liver Cancer
Gene >> SALL4
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. PMID: 20182341 |
Ref: alpha-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. PMID: 22516245 |
Ref: Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. PMID: 23175232 Ref: Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. PMID: 23347651 Ref: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. PMID: 23758232 Ref: Cancer: Importance of oncofetal gene, SALL4, in a subset of hepatocellular carcinoma. PMID: 23797869 Ref: Liver cancer: SALL4--a cancer marker and target. PMID: 23799373 Ref: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. PMID: 24047068 Ref: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. PMID: 24047069 Ref: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. PMID: 24047070 Ref: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. PMID: 24047071 Ref: Newly available antibodies with practical applications in surgical pathology. PMID: 24225578 |
Ref: The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. PMID: 24012616 Ref: SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases. PMID: 24805857 Ref: Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma. PMID: 24860834 Ref: Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update. PMID: 24901396 Ref: Molecular biology of liver cancer stem cells. PMID: 24944998 Ref: Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma. PMID: 26034695 |
Ref: SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis. PMID: 26265684 Ref: beta-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study. PMID: 26311355 Ref: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma. PMID: 26317546 |
Ref: Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma. PMID: 26267070 Ref: Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity. PMID: 26886287 Ref: Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. PMID: 26973422 Ref: Positive immunostaining of Sal-like protein 4 is associated with poor patient survival outcome in the large and undifferentiated Korean hepatocellular carcinoma. PMID: 27433461 Ref: [MicroRNA-33b inhibits cell proliferation in hepatocellular carcinoma via targeting SALL4]. PMID: 27640788 Ref: MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4. PMID: 27677076 Ref: Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin. PMID: 27725724 Ref: [Expression of sal-like 4 in primary hepatocellular carcinoma and its association with epithelial-mesenchymal transition]. PMID: 27784427 Ref: MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression. PMID: 28026002 |
Ref: DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection. PMID: 27797380 Ref: Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity. PMID: 28126467 Ref: Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma. PMID: 28411180 |
Ref: Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression. PMID: 29554896 Ref: Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion. PMID: 29593314 Ref: Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification. PMID: 29603348 Ref: Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide. PMID: 29976840 Ref: Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and H PMID: 30196987 |